Literature DB >> 6993647

Effect of sodium cyanate on Plasmodium falciparum in vitro.

R L Nagel, C Raventos, H B Tanowitz, M Wittner.   

Abstract

Sodium cyanate at concentrations as low as 0.5 mM inhibited the growth of Plasmodium falciparum (FCR-3 Strain) utilizing the Trager-Jensen continuous culture system. At concentration higher than 1 mM, the parasites were irreversibly destroyed. Utilizing synchronized cultures, the relative susceptibilities of early and late trophozite forms were examined, and it was found that both developmental forms were equally susceptible to the action of cyanate. Pretreatment of red cells with sodium cyanate prior to infection did not alter the intracellular growth of the parasite. Consequently, the effect of the drug is likely to be on the parasite per se rather than the red cell. The mechanism of action is probably the carbamylation of essential, parasite proteins that eventually impair growth and/or function. Published pharmacological studies in humans would predict that the level of cyanate at which growth inhibition occurs in vitro can be achieved in vivo and that the adverse effects will likely be minimal for short treatment periods.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993647

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  4 in total

Review 1.  African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping.

Authors:  Michael C Campbell; Sarah A Tishkoff
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

2.  Impairment of the growth of Plasmodium falciparum in HbEE erythrocytes.

Authors:  R L Nagel; C Raventos-Suarez; M E Fabry; H Tanowitz; D Sicard; D Labie
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

3.  Molecular adaptation of modern human populations.

Authors:  Hong Shi; Bing Su
Journal:  Int J Evol Biol       Date:  2010-12-30

4.  Millipedes as food for humans: their nutritional and possible antimalarial value-a first report.

Authors:  Henrik Enghoff; Nicola Manno; Sévérin Tchibozo; Manuela List; Bettina Schwarzinger; Wolfgang Schoefberger; Clemens Schwarzinger; Maurizio G Paoletti
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-12       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.